Table of Contents Table of Contents
Previous Page  142 / 398 Next Page
Information
Show Menu
Previous Page 142 / 398 Next Page
Page Background

137

Transforming growth factor-beta 1 and TbetaRII/Smad3

signalling pathway regulates the vascular endothelial growth

factor expression of tumour-associated macrophages in oral

squamous cell carcinoma

K.X. Yan

∗

, C.J. Li, H.B. Sun, L. Wang, L.J. Li

West China School of Stomatology, Sichuan University,

Chengdu, China

Objectives:

In this study, we aim to investigate the correlation

between macrophages and several prognosis-associated clinic-

pathological indicators and more importantly, how transforming

growth factor-beta 1 (TGF- 1) acts on the vascular endothelial

growth factor (VEGF) expression of macrophages.

Methods:

72 paraffin-embedded oral squamous cell carci-

noma (OSCC) samples were randomly selected for CD68 and

CD31 immunohistochemical staining to study the relationship of

macrophages quantity, microvascular density (MVD) and clini-

copathological features. Fresh OSCC tissues, metastatic lymph

nodes and non-metastatic lymph nodes were collected during

the surgery for CD68, CD206, iNOS and VEGF staining as

well as VEGF quantitative analysis. Macrophages induced from

C57BL/6J mouse bone marrow cells were stimulated by Cal

27 cells condition medium (CM) with or without neutralising

antibodies for TGF- 1 and T RII. Western blot, enzyme-linked

immunosorbent assay and quantitative real-time polymerase chain

reaction were applied to assess the expression of vascular endothe-

lial growth factor (VEGF) indifferent conditions.

Results:

High number of macrophages was directly correlated to

lower pathological differentiation degree, later of clinical stage

and lower survival rate. MVD also has positive correlation with

clinical stage and macrophages number. What’s more, OSCC-

associated macrophages expressed more VEGF than macrophages

in health lymph nodes. But when the TGF- 1 in Cal 27 cells CM

and the T RII in macrophages were neutralised or the Smad3 was

inhibited, the VEGF expression was down regulated too.

Conclusion:

Via the T RII/Smad3 signalling pathway, TGF- 1

can promote the OSCC-associated macrophages to secrete more

VEGF, an angiogenic factor of great importance.

http://dx.doi.org/10.1016/j.ijom.2017.02.475

Surgical management and follow-up of lateral skull base

tumours — an eight-year review

H.Y. Yang

Peking University Shenzhen Hospital, China

Background:

Lateral skull base tumour is a challenge for oral and

maxillofacial surgeons.

Objectives:

The purpose of this article is to describe the diagnostic

evaluation and surgical approaches to lateral skull base tumours

(LSBTs).

Methods:

The study is a retrospective review of 21 patients

diagnosed with tumours involving the lateral skull base (8 with

malignant diseases and 13 with benign lesions) and surgically

treated over an eight-year period.

Findings:

The transparotid-transmandibular (38%) was the most

commonly performed surgical procedures followed by the trans-

mandibular (24%), the transmaxillary (24%), the transcervical

approach (10%) and the combined approach (4%). The surgi-

cal procedures were uneventful and there were no postoperative

mortalities. Complications were encountered in eight cases, and

morbidity was not remarkable during perioperative stages. After

an average follow-up of 46 months, only 1 of 14 patients with

benign diseases had a recurrence following the resection of a pleo-

morphic adenoma. Of seven patients with malignant tumours, five

are alive with no evidence of disease.

Conclusion:

Most of benign lateral skull base tumours can be

removed surgically with a low rate of complications and recur-

rence. However, malignant neoplasms carry a poor prognosis and

a low rate of disease-free survival.

http://dx.doi.org/10.1016/j.ijom.2017.02.476

L

ow-dose prophylaxis for Chinese haemophilia children

involving maxillary haemophilic pseudotumours

G.X. Yu

∗

, H. Zhu, R.H. Wu

Department of Stomatology, Beijing Children’s Hospital,

Capital Medical University, China

Background:

The incident of haemophilic pseudotumour in

patients with haemophilia is estimated to be 1–2%,

∼

5–10%

among them occurring in maxilla. Patients with maxillary

haemophilic pseudotumour often visit dental clinics with com-

plaints of orofacial swelling and/or gingival bleeding and most of

them were misdiagnosed to be malignant tumours — they then

undergo repeated biopsies and invasive surgeries that is harmful

to children’s craniofacial upgrowth. Therefore, it is important to

improve diagnostic accuracy and provide timely treatment.

Methods:

There were seven cases of maxillary haemophilic pseu-

dotumour at our hospital between 2006 and 2014, with 6 cases of

haemophilia A and 1 case of haemophilia B. We retrospectively

analysed patients’ medical histories, physical examinations and

laboratory and image information. We treated the patients with

replacement therapy, most of them we choose the low-dose pro-

phylaxis (10–20 U/kg, QW), swelling and pain subsided in six

patients and one patient underwent surgery without replacement

therapy. We then observed the evolution of replacement treatment,

clinical and image observations.

Results:

(1) Diagnosis: five patients initially presented at other hospitals

were misdiagnosed as malignant tumours.

(2) After short-term (three to six months) low-dose prophylaxis,

recovery rate was 86% patients (assessed by clinicians and

radiologists).

Conclusion:

The oral surgeons should know more about

haemophilic pseudotumours, low-dose prophylaxis will be pre-

scribed for paediatric patients because of its clinical success,

noninvasive and effective for the haemophilic pseudotumours

involving the maxilla.

http://dx.doi.org/10.1016/j.ijom.2017.02.477